Skip to main content

Day: April 6, 2022

Qpr Software Plc: Resolutions of the Annual General Meeting and the organizing meeting of the Board of Directors of QPR Software Plc

STOCK EXCHANGE RELEASE, APRIL 6, 2022, 15:30 P.M. (EEST)Resolutions of the Annual General Meeting and the organizing meeting of the Board of Directors of QPR Software Plc The Annual General Meeting of QPR Software Plc was held today on April 6, 2022 in Helsinki. In order to ensure the health and safety of the shareholders, employees, and the Company’s other stakeholders, the Annual General Meeting was held without shareholders’ and their proxy representatives’ presence at the meeting venue. The minutes of the Annual General Meeting will be available on the Company’s website at www.qpr.com no later than on April 20, 2022. The Annual General Meeting of QPR Software Plc adopted the company’s annual accounts 2021 and discharged the members of the Board of Directors and the CEOs from the liability. Annual General Meeting resolved...

Continue reading

Celsion and Medidata to Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial

Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients to be presented at 2022 AACR Annual Meeting being held April 8-13 in New Orleans, LA LAWRENCEVILLE, N.J., April 06, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN) a clinical-stage company focused on DNA-based immunotherapy and next generation vaccines and Medidata, a Dassault Systèmes company, today announced that they will be presenting their findings on the use of a Synthetic Control ArmⓇ (SCA) in a completed Phase Ib dose-escalating study of GEN-1 in the neoadjuvant treatment of patients with Stage III/IV ovarian cancer (the OVATION 1 Study) at the Annual Meeting of the American Association for Cancer Research (AACR) being held on April 8-13, 2022 in New Orleans, LA. In a poster presentation entitled “Phase IB trial efficacy estimates...

Continue reading

Loop Media, Inc. Enters Integration with SpringServe to Power Advertising Across Video-Centric DOOH Channels

Digital Out Of Home (“DOOH”) Music-Forward Streaming Leader Leverages SpringServe’s Ad Server to Bolster its Programmatic-First Approach GLENDALE, CA, April 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Loop Media, Inc., a leading multi channel streaming platform that provides curated music video and branded entertainment channels for businesses and consumers, today announced it has selected SpringServe as one of its ad servers. SpringServe’s ad serving technology will assist in enabling Loop Media to maximize ad inventory value and provide a premium quality ad experience for consumers. SpringServe’s platform incorporates features including frequency capping, competitive separation, ad volume and creative size targeting for optimal DOOH viewing. The SpringServe platform also allows for measurement of campaign performance and optimization...

Continue reading

Grayscale® Digital Large Cap Fund, Grayscale® DeFi Fund, and Grayscale® Smart Contract Platform Ex-Ethereum Fund Announce Rebalancing of Funds for First Quarter 2022

NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) — Grayscale Investments®, the world’s largest digital currency asset manager, and manager of Grayscale® Digital Large Cap Fund (OTCQX: GDLC) (Digital Large Cap Fund), Grayscale® DeFi Fund (DeFi Fund), and Grayscale® Smart Contract Platform Ex-Ethereum Fund (GSCPxE Fund), today announced the updated Fund Component weightings for each product in connection with their respective first quarter 2022 reviews. In accordance with the construction criteria, Grayscale has adjusted the Digital Large Cap Fund’s portfolio by selling certain amounts of the existing Fund Components in proportion to their respective weightings, and using the cash proceeds to purchase Avalanche (AVAX) and Polkadot (DOT). No tokens were removed from the Grayscale Digital Large Cap Fund. At the end of the day on April 5,...

Continue reading

Manhattan Associates Announces Date for Reporting First Quarter 2022 Financial Results

ATLANTA, April 06, 2022 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced it will release its first quarter 2022 financial results on Tuesday, April 26, 2022, after the stock market closes. The press release will be followed by a conference call hosted by Manhattan Associates senior management at 4:30 p.m. Eastern time, also on April 26, 2022. Investors are invited to listen to a live webcast of the conference call through the investor relations section of the Manhattan Associates website at ir.manh.com. To listen to the live webcast, please go to the website at least 15 minutes before the call to download and install any necessary audio software. For those who cannot listen to the live broadcast, a replay can be accessed shortly after the call by dialing +1-855-859-2056 in the U.S. and Canada, or +1-404-537-3406...

Continue reading

ARHT Media Announces the Engagement of Bristol Capital Ltd. for Investor Relations

TORONTO, April 06, 2022 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV:ART), (OTCQB:ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, announces that it has retained Bristol Capital Ltd. (“Bristol”) a leading investor relations firm servicing Canadian and US micro-cap and small-cap companies across international markets, to provide investor relations and communication services. Bristol has agreed to comply with all applicable securities laws and the policies of the TSX Venture Exchange (the “TSXV”) in providing the Services. Bristol has been engaged by the Company for an initial period of 12 months (the “Initial Term”) which shall be renewed automatically for successive one-year periods thereafter,...

Continue reading

Day One to Present at the 21st Annual Needham Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will present at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13 at 3:45 p.m. ET. A live audio webcast of the discussion will be available by visiting the Events & Presentations section of the Company’s website. An archived replay of the webcast will be available for 30 days following the live presentation. About Day One Biopharmaceuticals Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company developing targeted therapies for patients of all ages with life-threatening diseases. Day One...

Continue reading

Nauticus Robotics, Inc. Strengthens Management Team with Hiring of Chief Operating Officer

HOUSTON, Texas, April 06, 2022 (GLOBE NEWSWIRE) — Nauticus Robotics, Inc. (“Nauticus” or “Company”), a Houston-area developer of surface and subsea robots, autonomy software, and associated ocean services today announced the appointment of Donnelly Bohan as the Company’s new Chief Operating Officer, effective April 4, 2022. Ms. Bohan was most recently at Leidos (NYSE: LDOS), where for five years she served as Vice President, Division Manager of Leidos’ Maritime Solutions Division globally, ultimately serving as Vice President, Division Manager – Mission Operations and Infrastructure Protection Division. In this most recent role, Ms. Bohan oversaw day-to-day operations of over 850 employees in an organization providing electronic and integrated security systems including counter-small unmanned aerial systems. “It is...

Continue reading

Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting

SALT LAKE CITY, April 06, 2022 (GLOBE NEWSWIRE) — Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient management strategies for precancerous and cancerous esophageal diseases, today announced it will be giving a data presentation this week at the American Association for Cancer Research (AACR) Annual Meeting, which is being held April 8 – 13, 2022, at the Ernest N. Morial Convention Center in New Orleans, LA. The presentation will be given by Christopher P. Hartley, MD of the Mayo Clinic, a board certified pathologist, and principal investigator of Stella Diagnostics’ Collaborative Research Agreement with the Mayo Clinic to assess the performance of the Company’s STLA101 panel that detects and quantifies hallmarks of cancer development in tissue of patients diagnosed with Barrett’s...

Continue reading

Core One Labs’ Upgrades to OTCQB Venture Market

VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: “COOL”), (OTCQB: “CLABF”), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) a life sciences biotechnology research and development company focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of novel delivery systems technology is pleased to announce that it has received approval to upgrade from the OTC Pink Market to the OTCQB® Venture Market (the “OTCQB“). Core One will commence trading on the OTCQB effective at market open on April 6, 2022, under the symbol “CLABF” and investors can find quotes for the Company’s common shares on www.otcmarkets.com. The Company’s shares...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.